ArticleHeliyon2024

The anti-COVID-19 drug nirmatrelvir crosses the blood‒brain barrier and exhibits herb-drug pharmacokinetic interactions with

Wan-Hsin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.